miDiagnostics
PrivateLast Round
Series D
Dec 4, 2024
Total Funding Raised
$195.69M
Momentum Score
25 /100
Company Overview
miDiagnostics is a medical devices company that develops rapid, point-of-care diagnostic tests using silicon chip and nanofluidic technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Quality Management, Semiconductors, Sensors
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
miDiagnostics Comps
Public and private peers based on sector, stage, and business model.
miDiagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 4, 2024 | ||||
| Debt | Dec 7, 2021 | ||||
| Series C | Oct 14, 2021 | ||||
| Series B | Mar 26, 2020 | ||||
| Series A | May 28, 2015 |
Key People
Founding team and executive leadership
miDiagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alychlo | Series C, Series D, Series A, Series B |
| PMV | Series D, Series A, Series B |
| European Investment Bank | Debt |
| Smile Invest | Series C |
miDiagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about miDiagnostics's valuation, stock price, and market status.
